Clinical Trial Update: Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing alendronate to alfacalcidol for the prevention of glucocorticoid-induced osteoporosis in rheumatic disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Granulomatosis with Polyangiitis
• Polymyalgia Rheumatica
• Polymyositis
• Rheumatoid Arthritis

Drugs mentioned

• Alfacalcidol (alfacalcidol)
• alendronate (alendronate)

Snippet

Sponsor: UMC Utrecht | Conditions: Rheumatoid Arthritis, Polymyalgia Rheumatica | Phase 3 | Status: COMPLETED